Lunit Insight MMG South Korea's AI-based medical imaging equipment firm Lunit will export AI breast cancer diagnosis solutions to large hospitals in Hong Kong and Mongolia.
Lunit announced on Thursday that it has signed a contract to supply Lunit Insight MMG, an AI breast cancer screening solution, to Hong Kong Women's Imaging (HKWI), Hong Kong's largest diagnosis imaging center, and Mongolia's National Cancer Center.
Starting with this contract, the company expects to supply solutions to hospitals under the Hong Kong Hospital Authority, a Hong Kong public hospital management organization, and other hospitals in Mongolia.
"I hope this deal will serve as a bridgehead for entering East Asian countries such as China and Singapore," said Suh Beom-seok, CEO of Lunit.
We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.